Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)—validation in two independent cohorts

INTRODUCTION: Effective predictive biomarkers for selection of patients benefiting from adjuvant platinum-based chemotherapy in non-small cell lung cancer (NSCLC) are needed. Based on a previously validated methodology, molecular profiles of predicted sensitivity in two patient cohorts are presented...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:PLoS One
Autori principali: Buhl, Ida Kappel, Santoni-Rugiu, Eric, Ravn, Jesper, Hansen, Anker, Christensen, Ib Jarle, Jensen, Thomas, Pratt, Bruce, Askaa, Jon, Jensen, Peter Buhl, Knudsen, Steen, Sørensen, Jens Benn
Natura: Artigo
Lingua:Inglês
Pubblicazione: Public Library of Science 2018
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5864030/
https://ncbi.nlm.nih.gov/pubmed/29566065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0194609
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi